Package Quantity: 60/Bottle Active Ingredient: Crofelemer Presentation: Tablet Strength: 125 mg
Quantity
Choose a comparable product or call 1-800-225-7911 for assistance

Canalevia™-CA1 (crofelemer) Delayed-Release Tablets conditionally approved by the FDA for treatment of chemotherapy-induced diarrhea in dogs.

  • Normalizes water flow to reinstate normal function in the GI tract and is an antidiarrheal, enteric-coated tablet for oral administration
  • Acts locally and it is not absorbed into the blood stream, providing a well tolerated and nontoxic drug product
  • Only FDA conditionally approved product for chemotherapy-induced diarrhea (CID) in dogs
  • Modulates the hypersecretion of CI in CID and normalizes water influx into the intestinal lumen
  • Non-opioid
  • Reduces the instances of watery stools
  • Reduces costly accidents around the home, and improves the quality of life for dogs undergoing chemotherapy and their owners

Package Quantity: 60/Bottle Active Ingredient: Crofelemer Presentation: Tablet Strength: 125 mg NDC Number: 86149-0111-60 Color Of Medicine: White Delivery Type: Oral Container Capacity: Bottle Reconstitution Required: N NDC Number: 86149-0111-60